BNET Industries
Market Cap:$468.0M
Last Fiscal Year Sales:$423.1M
- Public
- US
Dow Jones Description
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, Philippines and the United Kingdom.
Number of Employees 948
Contact Information
3838 Parkway Blvd
Salt Lake City, Utah 84120-6336
(801) 954-7100
Peer Companies
NAICS Code Medicinal and Botanical Manufacturing: 325411
Recent Events
-
USANA Health Sciences Announces FY09 Q3 Results
-
USANA Launches Probiotic Plus
-
BRIEF-RESEARCH ALERT-Jefferies raises Nu Skin, USANA to buy
-
Thousands Flock to USANA Health Sciences 17th Annual
-
USANA Health Sciences Announces FY09 Q2 Results
News & Analysis
Filter by
sales and usana health sciences inc. - All News and Analysis
USANA Health Sciences Q2 2009 Earnings Transcript
Question-and-Answer SessionOperator Thank you, sir. We will now begin the question-and-answer session. Operator Instructions. And our first question comes from the line of Tim Ramey with D.A. Davidson. Please go ahead. Timothy Ramey - D.A. Davidson Good morning, guys. Congratulations on some good results. Jeff Yates Thank you, Tim....
USANA Health Sciences Q4 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Thank you, sir. Ladies and gentlemen, we will now begin the question-and-answer session. Operator Instructions. And our first question comes from Tim Ramey with D.A. Davidson and Company. Go ahead, please. Timothy Ramey - D.A. Davidson Good morning, guys. Jeff Yates Good morning. Fred Cooper, Ph.D. Hi,...
USANA Health Sciences Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of [Simian Dutman] – Goldman Sachs. [Simain Dutman] – Goldman Sachs A couple of questions, first, on the matching promotion, you mention in the remarks that some of the sales probably were pushed into the second...
Gull Holdings Reaffirms Offer to Purchase Publicly-Held Shares of USANA Health Sciences, Inc. at $26.00 per Share
SALT LAKE CITY -- Gull Holdings, Ltd. and Unity Acquisition Corp. today reaffirmed their offer to purchase the outstanding shares of USANA Health Sciences, Inc. (NASDAQ:USNA) at $26.00 per share after USANA's announcement of preliminary second quarter 2008 results and the filing by USANA with the SEC of an amended...
USANA Health Sciences Inc. in Progressive Review.
M2 PRESSWIRE-11 January 2008-Market Review: USANA Health Sciences Inc. in Progressive ReviewC1994-2008 M2 COMMUNICATIONS LTD RDATE:11012008 Thursday saw an un-expectant fall for newly laid off workers filing claims for unemployment benefits. However, this decline which caught analysts by surprise is not...
Earnings roundup
Usana Usana Health Sciences Inc., based in Salt Lake City, reported net income of $10.2 million, or 55 cents per share, for the third fiscal quarter ended Sept. 29. That compares with $11.3 million, or 68 cents per share, for the same quarter in 2006. Sales...
Earnings roundup
Several companies, including some based in Utah or with ties to the state, reported quarterly earnings results on Tuesday. Wells Fargo Rising core deposits and loans boosted first-quarter income at Wells Fargo & Co. 11 percent, despite growing problems in its subprime mortgage portfolio. ...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
USANA Health Sciences
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes

